QS Investors’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$321K Hold
15,900
﹤0.01% 919
2021
Q1
$292K Hold
15,900
﹤0.01% 993
2020
Q4
$320K Sell
15,900
-4,900
-24% -$95.4K ﹤0.01% 963
2020
Q3
$390K Sell
20,800
-48,137
-70% -$969K 0.01% 816
2020
Q2
$1.55M Sell
68,937
-437
-0.6% -$8K 0.02% 586
2020
Q1
$1.03M Sell
69,374
-1,818
-3% -$31.6K 0.02% 656
2019
Q4
$1.38M Sell
71,192
-1,255
-2% -$24.1K 0.01% 696
2019
Q3
$1.44M Hold
72,447
0.02% 670
2019
Q2
$1.53M Sell
72,447
-1,832
-2% -$38.3K 0.02% 671
2019
Q1
$1.52M Hold
74,279
0.02% 705
2018
Q4
$1.48M Hold
74,279
0.02% 663
2018
Q3
$1.43M Hold
74,279
0.01% 721
2018
Q2
$1.13M Hold
74,279
0.01% 753
2018
Q1
$1.39M Sell
74,279
-4,785
-6% -$89.9K 0.01% 695
2017
Q4
$1.52M Sell
79,064
-619
-0.8% -$11.6K 0.01% 675
2017
Q3
$1.42M Sell
79,683
-1,886
-2% -$31K 0.01% 718
2017
Q2
$1.46M Hold
81,569
0.01% 678
2017
Q1
$1.18M Hold
81,569
0.01% 758
2016
Q4
$1.5M Buy
81,569
+6,543
+9% +$127K 0.01% 681
2016
Q3
$1.42M Buy
75,026
+50,019
+200% +$908K 0.01% 713
2016
Q2
$403K Buy
+25,007
New +$353K ﹤0.01% 946

Other funds holding AMPH

QS Investors's AMPH Position: Q2 2021 in Review

QS Investors held its Amphastar Pharmaceuticals (AMPH) position steady in Q2 2021 at 15,900 shares worth $321K. The position accounts for ﹤0.01% of the portfolio, ranked #919.

QS Investors first reported a position in AMPH in Q2 2016 and has held it in 21 quarters since. The position peaked at $1.55M in Q2 2020. 146 funds tracked by Wall St. Rank hold AMPH as of Q2 2021.

  • QS Investors held 15,900 shares of Amphastar Pharmaceuticals worth $321K as of Q2 2021.
  • QS Investors left its Amphastar Pharmaceuticals share count unchanged in Q2 2021.
  • Amphastar Pharmaceuticals made up ﹤0.01% of QS Investors's portfolio in Q2 2021, its #919 holding.
  • QS Investors first reported a position in Amphastar Pharmaceuticals in Q2 2016 and has held it in 21 quarters since.
  • QS Investors's Amphastar Pharmaceuticals position peaked at $1.55M in Q2 2020.
  • 146 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2021.

Based on QS Investors's 13F filing for Q2 2021, filed 13 Aug 2021.